Results 161 to 170 of about 208,254 (303)
This study reveals the dual role of celecoxib in intervertebral disc degeneration. While low concentrations are protective, high concentrations induce toxicity by upregulating HSP90, which synergizes with USP15 to deubiquitinate and stabilize RBX1. This leads to degradation of COMMD1/ATP7B, copper dyshomeostasis, and ultimately, cuproptosis.
Youfeng Guo +11 more
wiley +1 more source
An armed anti-immunoglobulin light chain nanobody protects mice against influenza A and B infections. [PDF]
Liu X +3 more
europepmc +1 more source
A straightforward method is introduced to produce ion‐gel films with very low surface roughness by employing a solution‐shearing coating process. These ion‐gel films permit the growth of crystalline thin films of various small molecule organic semiconductor molecules directly on top of the ion‐gel layer, thereby enabling “inverted” small molecule ...
Jonathan Perez Andrade +10 more
wiley +1 more source
Alterations of the gut microbiota in patients with immunoglobulin light chain amyloidosis. [PDF]
Yan J +14 more
europepmc +1 more source
This work presents lightweight, lignin‐derived carbon fiber current collectors that enable controlled lithium deposition. Structural defects and intermediate‐sized pores stabilize pre‐nucleation quasi‐metallic lithium clusters, promoting uniform lithium plating and stripping.
Samantha L. S. Southern +13 more
wiley +1 more source
Comparative analysis of the organization and complexity of immunoglobulin light chain loci in equids. [PDF]
Qiu Y +6 more
europepmc +1 more source
Prognostic value of right ventricular global longitudinal strain in patients with immunoglobulin light-chain cardiac amyloidosis. [PDF]
Usuku H +19 more
europepmc +1 more source
ABSTRACT Patients with relapsed/refractory multiple myeloma (RRMM) who are penta‐drug refractory, defined as resistant to two proteasome inhibitors, two immunomodulatory agents, and an anti‐CD38 monoclonal antibody, face a dismal prognosis, particularly after exposure to T‐cell–redirecting therapies.
Maximilian Al‐Bazaz +22 more
wiley +1 more source
Safety and efficacy of elranatamab in patients with relapsed and/or refractory immunoglobulin light-chain amyloidosis. [PDF]
Vianna P +10 more
europepmc +1 more source
Immunoglobulin Light Chain (AL) Amyloidosis Preceding Marginal Zone Lymphoma: A Case Report. [PDF]
Doshi K, Bitran J, Adley B, Asado N.
europepmc +1 more source

